| pubmed-article:15336718 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15336718 | lifeskim:mentions | umls-concept:C0000769 | lld:lifeskim |
| pubmed-article:15336718 | lifeskim:mentions | umls-concept:C0031575 | lld:lifeskim |
| pubmed-article:15336718 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
| pubmed-article:15336718 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15336718 | pubmed:dateCreated | 2004-8-31 | lld:pubmed |
| pubmed-article:15336718 | pubmed:abstractText | The question of how alterations in cell behavior produced by retinoic acid (RA) influenced the development of skeletogenic mesenchyme of the limb bud was examined in this study. Our established model was employed, which involves treatment of pregnant mice with a teratogenic dose of RA (100 mg/kg) on 11 days postcoitum (dpc) resulting in a severe truncation of all long bones of the forelimbs in virtually every exposed fetus. It is shown that RA, administered at a stage to induce phocomelia in virtually all exposed embryos, resulted in immediate appearance of enhanced cell death within the mesenchyme in the central core of the limb bud, an area destined for chondrogenesis. The central core mesenchyme, which in the untreated limb buds experiences a sharp decline in cell proliferation heralding the onset of chondrogenesis, demonstrated a reversal of the process; this mesenchyme maintained a higher rate of cell proliferation upon RA exposure. These events resulted in a truncation and disorganization of the chondrogenic anlage, more pronounced in zeugopodal mesenchyme than in the autopod. We conclude that an inhibition of chondrogenesis was secondary to a disruption in cellular behavior caused by RA, a likely consequence of misregulation in the growth factor signaling cascade. | lld:pubmed |
| pubmed-article:15336718 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15336718 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15336718 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15336718 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15336718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15336718 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15336718 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15336718 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:15336718 | pubmed:issn | 0890-6238 | lld:pubmed |
| pubmed-article:15336718 | pubmed:author | pubmed-author:ZhouJianJ | lld:pubmed |
| pubmed-article:15336718 | pubmed:author | pubmed-author:KochharDevend... | lld:pubmed |
| pubmed-article:15336718 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15336718 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:15336718 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15336718 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15336718 | pubmed:pagination | 103-10 | lld:pubmed |
| pubmed-article:15336718 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:meshHeading | pubmed-meshheading:15336718... | lld:pubmed |
| pubmed-article:15336718 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15336718 | pubmed:articleTitle | Cellular anomalies underlying retinoid-induced phocomelia. | lld:pubmed |
| pubmed-article:15336718 | pubmed:affiliation | Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, 1020 Locusts Street, 506 Jefferson Alumini Hall, Philadelphia, PA 19107, USA. | lld:pubmed |
| pubmed-article:15336718 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15336718 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
